• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the CO

tetano

Editor, Senior Moderator
PLoS One


. 2024 May 22;19(5):e0303892.
doi: 10.1371/journal.pone.0303892. eCollection 2024. Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the COVID-19 schools infection survey (SIS) and the COVID-19 mapping and mitigation in schools (CoMMinS) study

Katharine J Looker[SUP] 1 2 [/SUP], Elliot McClenaghan[SUP] 3 [/SUP], Alison Judd[SUP] 4 [/SUP], Livia Pierotti[SUP] 1 2 5 [/SUP], Harriet Downing[SUP] 1 2 [/SUP], Jody Phelan[SUP] 6 [/SUP], Charlotte Warren-Gash[SUP] 7 [/SUP], Kalu Ngozi[SUP] 3 [/SUP], Fiona Dawe[SUP] 4 [/SUP], Caroline Relton[SUP] 1 5 8 9 [/SUP], Hannah Christensen[SUP] 1 [/SUP], Alastair D Hay[SUP] 1 2 [/SUP], Punam Mangtani[SUP] 3 [/SUP], Patrick Nguipdop-Djomo[SUP] 3 [/SUP], Rachel Denholm[SUP] 1 2 5 10 [/SUP]



Affiliations
Abstract

Background: The symptom profiles of acute SARS-CoV-2 infection and long-COVID in children and young people (CYP), risk factors, and associated healthcare needs, are poorly defined. The Schools Infection Survey 1 (SIS-1) was a nationwide study of SARS-CoV-2 infection in primary and secondary schools in England during the 2020/21 school year. The Covid-19 Mapping and Mitigation in Schools (CoMMinS) study was conducted in schools in the Bristol area over a similar period. Both studies conducted testing to identify current and previous SARS-CoV-2 infection, and recorded symptoms and school attendance. These research data have been linked to routine electronic health record (EHR) data.
Aims: To better understand the short- and long-term consequences of SARS-CoV-2 infection, and their risk factors, in CYP.
Methods: Retrospective cohort and nested case-control analyses will be conducted for SIS-1 and CoMMinS data linked to EHR data for the association between (1) acute symptomatic SARS-CoV-2 infection and risk factors; (2) SARS-CoV-2 infection and long-term effects on health: (a) persistent symptoms; (b) any new diagnosis; (c) a new prescription in primary care; (d) health service attendance; (e) a high rate of school absence.
Results: Our study will improve understanding of long-COVID in CYP by characterising the trajectory of long-COVID in CYP in terms of things like symptoms and diagnoses of conditions. The research will inform which groups of CYP are more likely to get acute- and long-term outcomes of SARS-CoV-2 infection, and patterns of related healthcare-seeking behaviour, relevant for healthcare service planning. Digested information will be produced for affected families, doctors, schools, and the public, as appropriate.
Conclusion: Linked SIS-1 and CoMMinS data represent a unique and rich resource for understanding the impact of SARS-CoV-2 infection on children's health, benefiting from enhanced SARS-CoV-2 testing and ability to assess a wide range of outcomes.


 
Back
Top Bottom